CENCOSUD:BCSCencosud S.A. Analysis
Data as of 2026-06-13 - not real-time
CLP 2,248.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Cencosud is trading at 2,248 CLP, comfortably above its 20‑day SMA of 2,137 but still below the 50‑day (2,272) and 200‑day (2,716) averages, signaling a short‑term bounce within a longer‑term bearish backdrop. The RSI of 56 points to neutral momentum, while the MACD histogram has turned positive, giving the technical signal a modest bullish tilt despite the overall bearish trend. Volatility remains elevated at over 43% 30‑day and beta is modest at 0.53, indicating the stock moves less than the market but can swing sharply on news. Fundamentals show a flat revenue growth of 0.2%, thin profit margins (1.7%), and a very high debt‑to‑equity ratio near 99, which tempers the appeal of the forward P/E of 17.2 and the price‑to‑book of 1.25 that suggest the stock is not dramatically overvalued. The dividend yield of 1.15% with a low payout ratio (14%) is supported by positive free cash flow, yet the heavy leverage raises questions about long‑term sustainability. Recent Q1 results highlighted operational gains in Peru and Colombia that helped offset foreign‑exchange headwinds, providing a modest earnings lift but underscoring the company’s exposure to regional macro‑economic and currency dynamics.
Analyst consensus remains a “hold” with a median target of 3,000 CLP, implying roughly 33% upside from current levels. The market sentiment index sits at an “Extreme Greed” 89.86, suggesting investors are currently optimistic, but the combination of high debt, sector cyclicality, and currency risk warrants a cautious approach. Investors should weigh the short‑term technical bounce against the longer‑term leverage concerns and the modest growth outlook before deciding on positioning.
Analyst consensus remains a “hold” with a median target of 3,000 CLP, implying roughly 33% upside from current levels. The market sentiment index sits at an “Extreme Greed” 89.86, suggesting investors are currently optimistic, but the combination of high debt, sector cyclicality, and currency risk warrants a cautious approach. Investors should weigh the short‑term technical bounce against the longer‑term leverage concerns and the modest growth outlook before deciding on positioning.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price approaching short‑term resistance around 2,260 CLP
- Elevated volatility and modest bullish MACD histogram
- High leverage limiting upside in a bearish trend
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Upside potential to median target of 3,000 CLP (~33% upside)
- Forward earnings improvement and low dividend payout ratio
- Stable free cash flow supporting dividend sustainability
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Persistent high debt‑to‑equity ratio constraining long‑term flexibility
- Consumer‑cyclical exposure to multiple Latin American economies
- Modest growth prospects and neutral valuation multiples
Key Metrics & Analysis
Financial Health
Revenue Growth0.20%
Profit Margin1.70%
P/E Ratio21.5
ROE6.89%
ROA3.43%
Debt/Equity99.06
P/B Ratio1.2
Op. Cash FlowCLP1166.6B
Free Cash FlowCLP328.5B
Technical Analysis
TrendBearish
RSI56.1
SupportCLP 2,051.00
ResistanceCLP 2,260.10
MA 20CLP 2,137.12
MA 50CLP 2,272.28
MA 200CLP 2,715.71
MACDBullish
VolumeStable
Fear & Greed Index89.86
Valuation
Target PriceCLP 2,990.00
Upside/Downside33.01%
GradeFair
TypeBlend
Dividend Yield1.15%
Risk Assessment
Beta0.53
Volatility43.69%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.